KIR-HLA Functional Repertoire Influences Trastuzumab Efficiency in Patients With HER2-Positive Breast Cancer

Trastuzumab induced a high rate of pathological Complete Response (pCR) in patients affected by locally advanced HER2-positive Breast Cancer (HER2-BC), by exploiting immune-mediated mechanisms as Antibody-Dependent Cell Cytotoxicity (ADCC) involving Natural Killer (NK) cells. Host’s immune genetics...

Descripción completa

Detalles Bibliográficos
Autores principales: Muraro, Elena, De Zorzi, Mariangela, Miolo, Gianmaria, Lombardi, Davide, Scalone, Simona, Spazzapan, Simon, Massarut, Samuele, Perin, Tiziana, Dolcetti, Riccardo, Steffan, Agostino, De Re, Valli
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Immunology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8790064/
https://www.ncbi.nlm.nih.gov/pubmed/35095867
http://dx.doi.org/10.3389/fimmu.2021.791958

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8790064/
https://www.ncbi.nlm.nih.gov/pubmed/35095867
http://dx.doi.org/10.3389/fimmu.2021.791958

Ejemplares similares